Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
The American Journal of Medicine
|
March 25, 2019
What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes
Richard A Ferraro, Caitlin M Nass, Ramzi Dudum, et al.
Abdominal Imaging
|
October 24, 2002
Heterotopic pregnancy: case report
M Nass Duce, C Ozer, H Egilmez, et al.
Journal of General Internal Medicine
|
August 16, 2019
Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making
Sudipa Sarkar, Olusola A Orimoloye, Caitlin M Nass, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
August 1, 1996
Family practice in Saudi Arabia: chronic morbidity and quality of care
S A al-Shammari, M Nass, M A al-Maatouq, et al.
Molecular and Cellular Biochemistry
|
February 4, 1977
Studies of mitochondria and mitochondrial DNA extracted from organelles harboring an intramitochondrial virus
W Klietmann, P R Andersen, P D Lunger, et al.
Chest
|
September 14, 2001
Lipid disorders: justification of methods and goals of treatment
J B Braunstein, A Cheng, G Cohn, et al.
Nature
|
August 9, 1979
Light-activated drug confirms a mechanism of ion channel blockade
H A Lester, M E Krouse, M M Nass, et al.
Current Cardiology Reports
|
September 12, 2000
Global risk assessment for lipid therapy to prevent coronary heart disease
C M Nass, S D Wiviott, J K Allen, et al.
Cardiology in Review
|
February 24, 2001
ABCs of cardiovascular disease risk management
J B Braunstein, A Cheng, C Fakhry, et al.
The Journal of General Physiology
|
February 1, 1980
A covalently bound photoisomerizable agonist: comparison with reversibly bound agonists at Electrophorus electroplaques
H A Lester, M E Krouse, M M Nass, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
The American Journal of Medicine
|
March 25, 2019
What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes
Richard A Ferraro, Caitlin M Nass, Ramzi Dudum, et al.
Abdominal Imaging
|
October 24, 2002
Heterotopic pregnancy: case report
M Nass Duce, C Ozer, H Egilmez, et al.
Journal of General Internal Medicine
|
August 16, 2019
Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making
Sudipa Sarkar, Olusola A Orimoloye, Caitlin M Nass, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
August 1, 1996
Family practice in Saudi Arabia: chronic morbidity and quality of care
S A al-Shammari, M Nass, M A al-Maatouq, et al.
Molecular and Cellular Biochemistry
|
February 4, 1977
Studies of mitochondria and mitochondrial DNA extracted from organelles harboring an intramitochondrial virus
W Klietmann, P R Andersen, P D Lunger, et al.
Chest
|
September 14, 2001
Lipid disorders: justification of methods and goals of treatment
J B Braunstein, A Cheng, G Cohn, et al.
Nature
|
August 9, 1979
Light-activated drug confirms a mechanism of ion channel blockade
H A Lester, M E Krouse, M M Nass, et al.
Current Cardiology Reports
|
September 12, 2000
Global risk assessment for lipid therapy to prevent coronary heart disease
C M Nass, S D Wiviott, J K Allen, et al.
Cardiology in Review
|
February 24, 2001
ABCs of cardiovascular disease risk management
J B Braunstein, A Cheng, C Fakhry, et al.
The Journal of General Physiology
|
February 1, 1980
A covalently bound photoisomerizable agonist: comparison with reversibly bound agonists at Electrophorus electroplaques
H A Lester, M E Krouse, M M Nass, et al.
Page
of 8